SUPERNO2VA™ Nasal PAP Ventilation System
Delivers positive airway pressure to stent open the upper airway, allowing for the preoperative delivery of positive pressure ventilation and oxygen for patients with a decreased level of consciousness. The SuperNO2VA™ nasal PAP ventilation device is available in medium and large sizes and is offered as a standalone mask with a head strap and as a system, kitted with a hyperinflation bag. These configurations offer flexibility as it allows the SuperNO2VA™ nasal PAP ventilation device to be used with either an anesthesia machine or with only an oxygen flow meter.
Features & Benefits
- Relieve upper airway obstruction due to decreased level of consciousness
- Maintain ventilation
- Rescue ventilate
- Ease access for intra-oral procedures
- Be used peri-operatively
Please note that all products, services, or features of products and services may not be available in your local area. Please check with your local Vyaire representative.
Positive Nasal Pressure
- Reduce the risk of hypoxemia due to upper airway obstruction in patients with a decreased level of consciousness
- Stent open the upper airway to oxygenate patients before, during, and after surgery anywhere an oxygen source exists
- Allow for nasal positive pressure delivery with open access to the oral cavity for procedures
Deliver both nasal positive airway pressure and oxygen.
Can be connected direct to an oxygen flow meter
Kitted option requires only an oxygen source to deliver support
There are several therapies used to reduce the risk of perioperative hypoxemia in adult patients. They include: CPAP/NIV, nasal PAP ventilation, nasal high flow, and other means of oxygen delivery (oxygen masks and oxygen nasal cannula). CPAP/NIV and nasal PAP devices deliver both positive pressure ventilatory support and oxygen.
Some of these therapies DELIVER OXYGEN, BUT NOT VENTILATORY SUPPORT. They include: nasal high flow oxygen therapy, and oxygen delivery via an oxygen mask or nasal cannula.
Ventilatory support may offer benefits for sedated patients at risk of hypoxemia due to upper airway obstruction. There are several studies which recommend the use of nasal CPAP (nCPAP) in particular versus oxygen delivery as it does not include a ventilatory support component.
The Latest News From Vyaire
CHICAGO – August 19, 2019 ― Vyaire Medical, Inc., the healthcare industry’s dedicated “breathing company,” today announced the U.S.Read More
CHICAGO – June 7, 2019 – Vyaire Medical, a leader in global respiratory care, announces the appointment of Lisa Rose, Chief Marketing and Innovation Officer, and Debra Goetz, Chief Brand and Digital Officer to the Vyaire Executive Leadership team.Read More